Biogen Inc. buy Royal Bank of Canada
Start price
19.09.24
/
50%
€180.40
Target price
19.09.25
€262.25
Performance (%)
-4.02%
Price
26.09.24
€173.15
Summary
This prediction is currently active. With a performance of -4.02%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 19.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Biogen Inc. | -4.442% |
iShares Core DAX® | 0.936% |
iShares Nasdaq 100 | 3.064% |
iShares Nikkei 225® | 1.898% |
iShares S&P 500 | 1.653% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $292.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat